共 2 条
[1]
National Institute for Health and Care Excellence, 2025, Exagamglogene autotemcel for treating severe sickle cell disease in people 12 years and over
[2]
UK regulator approves "groundbreaking" gene treatment for sickle cell and β thalassaemia
[J].
BMJ-BRITISH MEDICAL JOURNAL,
2023, 383